Arkolith/Insider Trading/PTCT/Form 4

Boulding Mark Elliott

EXEC. VP AND CLOPTC THERAPEUTICS, INC. (PTCT) · full profile →Form 4 · filed Jul 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$432K
Net Open-Market Flow
-$432K
Transactions
12
10 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 6, 2026Option exercise(M)2K$39.42$89K108K
Jul 6, 2026Sell(S)313$83.10$26K107K
Jul 6, 2026Sell(S)833$84.41$70K106K
Jul 6, 2026Sell(S)519$85.84$45K106K
Jul 6, 2026Sell(S)601$86.38$52K105K
Jul 6, 2026Option exercise(M)3K$46.54$131K108K
Jul 6, 2026Sell(S)387$83.10$32K108K
Jul 6, 2026Sell(S)1K$84.41$87K107K
Jul 6, 2026Sell(S)645$85.84$55K106K
Jul 6, 2026Sell(S)745$86.38$64K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 6, 2026Option exercise(M)2K—$05K
Jul 6, 2026Option exercise(M)3K—$028K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001578852-26-000020) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML